Fexopen 120 Tablet
By Fexopen
Rx
10 Tablet in a Strip

Composition
Fexofenadine(120mg)

Manufacturer - Morepen Laboratories Ltd
409, Antriksh Bhawan, 22 Kasturba Gandhi Marg, New Delhi - 110 001

Expires on or after
July, 2025

liver
When it comes to the safety of using Fexopen 120 Tablet for individuals with liver disease, the available data indicates that it is likely safe. There is not enough information to suggest that adjusting the dosage of Fexopen 120 Tablet is necessary for patients with liver issues. However, it is always wise to seek advice from your doctor before starting any medication, including Fexopen 120 Tablet. Consulting with your healthcare provider will help ensure that the treatment is suitable for your specific liver condition.

kidney
Fexopen 120 Tablet requires caution in individuals with kidney problems, as dose adjustment may be necessary. Consult your doctor before use. It can lead to increased drowsiness in those with end-stage kidney disease.

alcohol
Consult your doctor when consuming alcohol with Fexopen 120 Tablet.

driving
Before driving or operating machinery while taking Fexopen 120 Tablet, ensure it does not cause drowsiness or dizziness. Observe how you feel to avoid impairment while driving.

pregnancy
Fexopen 120 Tablet should be avoided during pregnancy as it may not be safe. Limited human studies suggest potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before use.

breastfeeding
Fexopen 120 Tablet is considered safe for use during breastfeeding. Studies show the drug does not transfer to breastmilk in significant amounts, posing no harm to babies. Due to low milk levels and minimal side effects, it is not expected to cause adverse effects in breastfed infants.
Habit Forming | No |
Chemical Class | Diphenylmethane Derivative |
Therapeutic Class | RESPIRATORY |
Action Class | H1 Antihistaminics (second Generation) |
₹99
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 18-Nov-2024